Dottorato in Medicina Molecolare

VII Immunology and Cell Biology Doctorate Day, 14 dicembre 2012

Anno accademico 2011/2012

Sommario insegnamento

• Programma
• Strumenti didattici
• Scheda del corso

Programma

8.30               Registration and attendance control
8.45-9.00       Opening remarks Prof.ssa Giovarelli Mirella
9.00-11.05     XXIV CYCLE Oral Presentations (20 minutes + 5 minutes discussion)
9.00              Dr. Bandini Silvio “Complement-dependent surveillance against HER-2/neu carcinomas in   transgenic female mice”
9.25              Dr. Chattaragada Michelle Samuel “Characterization of novel pancreatic cancer associated antigen involved in regulation of tumour invasion”
9.50              Dr. D’Avino Lucia “Memory B-cells and Autoantibodies”
10.15            Dr. Granato Anna Maria “Immunological and antigenic characterization of tumor tissue of patients with advanced melanoma underwent Dendritic Cell vaccination”
10.40            Dr. Macagno Marco “Perforin-dependent immune surveillance of ErbB2+ carcinomas in female and male mice”
11.05-11.30  Coffe break
11.30–12.15  XXVI CYCLE Poster Session (5 minutes + 5 minutes discussion)
                    Dr. Barbero Daniela “Pre-emptive Rituximab-based treatment of molecular relapses in follicular and mantle cell lymphoma”
                    Dr. Genuardi Elisa “Telomeres shorten during chronic lymphocytic leukemia (CLL) evolution: an analysis on 88 cases”
                    Dr. Landra Indira “Humanized NOD/SCID/IL2g-/- tumor grafts outline the discovery of novel pathogenetic lesions and define personalized protocols in anaplastic large cell lymphoma”
                    Dr. Principe Moitza “Effects of alpha-enolase silencing in pancreatic adenocarcinoma cell line”
12.15-13.00   Lecture of Dr. Nisticò Paola, Regina Elena National Cancer Institute, Roma “From cancer patients’ immune response to prognostic markers and drugable pathways”
13.00-14.00   Lunch Time
14.00-15.00   XXVII CYCLE Poster Session (5 minutes + 5 minutes discussion)
                    Dr. Allizond Valeria “Phagocytes in multiple sclerosis: altered microbicidal functions related to the disease”
                    Dr. Barutello Giuseppina “A vaccine targeting Angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors”
                    Dr. Crescenzo Ramona “Novel tyrosine kinase chimeras pinpoint alternative mechanisms of transformation in ALK- ALCL”
                    Dr. Ferry-Borgogno Sammy “Characterization of circulating autoantibodies to post-translationally modified α-Enolase in Pancreatic Ductal Adenocarcinoma”
                    Dr. Griggio Valentina “Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA)”
                    Dr. Mereu Elisabetta “Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma”
15.00-16.45   XXV CYCLE Oral Presentations (10 minutes + 5 minutes discussion)
15.00             Dr. Riccardo Federica “Vaccination with a DNA coding for human CSPG4 protein increases the survival of dogs with oral malignant melanoma”
15.15             Dr. Castella Barbara “Immunoparesis of bone marrow Vgamma9Vdelta2 T cells in human multiple myeloma”
15.30             Dr. Gatti Deborah “Interplay between Human Cytomegalovirus and the interferon-inducible protein IFI16”
15.45             Dr. Luganini Anna “Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers”
16.00             Dr. Occhipinti Sergio “Efficient induction of HER-2 specific anti-tumor response by dendritic cells transfected with HER-2 rat/human hybrid plasmid”
16.15             Dr. Rigoni Micol Maria “The  mevalonate pathway as a metabolic target to circumvent multidrug-resistance in chronic lymphocytic leukemia cells (CLL)”
16.30             Dr. Spaccarotella Elisa “STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK positive Anaplastic Large Cell Lymphoma”
17.00             Concluding remarks

• Materiale didattico
• Bacheca appelli
• Orario lezioni
• Vai a Moodle
• Registrati a questo insegnamento
• Studenti registrati
• Invia email agli studenti registrati
• Esporta tabella